BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol 2020;94:1085-133. [PMID: 32249347 DOI: 10.1007/s00204-020-02693-7] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Corli G, Tirri M, Arfè R, Marchetti B, Bernardi T, Borsari M, Odoardi S, Mestria S, Strano-rossi S, Neri M, Gaudio RM, Bilel S, Marti M. Pharmaco-Toxicological Effects of Atypical Synthetic Cathinone Mephtetramine (MTTA) in Mice: Possible Reasons for Its Brief Appearance over NPSs Scene. Brain Sciences 2023;13:161. [DOI: 10.3390/brainsci13020161] [Reference Citation Analysis]
2 Tirri M, Corli G, Arfè R, Marchetti B, Bilel S, Bernardi T, Boccuto F, Odoardi S, Mestria S, Strano-rossi S, Marti M. Behavioral and Pharmacokinetics Studies of N-Methyl-2-Aminoindane (NM2AI) in Mice: An Aminoindane Briefly Used in the Illicit Drug Market. IJMS 2023;24:1882. [DOI: 10.3390/ijms24031882] [Reference Citation Analysis]
3 Marchetti B, Bilel S, Tirri M, Arfè R, Corli G, Roda E, Locatelli CA, Cavarretta E, De Giorgio F, Marti M. The Old and the New: Cardiovascular and Respiratory Alterations Induced by Acute JWH-018 Administration Compared to Δ(9)-THC-A Preclinical Study in Mice. Int J Mol Sci 2023;24. [PMID: 36675144 DOI: 10.3390/ijms24021631] [Reference Citation Analysis]
4 Rodrigues CHP, Mariotto LS, Castro JS, Peruquetti PH, Silva-Junior NC, Bruni AT. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances. Forensic Toxicol 2023. [PMID: 36604359 DOI: 10.1007/s11419-022-00657-3] [Reference Citation Analysis]
5 Couch AN, Sharp J, Davidson JT. Assessing the effectiveness of the NIST DART-MS Forensics Database and Data Interpretation Tool for designer drug screening with alternative instrumentation. International Journal of Mass Spectrometry 2023;483:116964. [DOI: 10.1016/j.ijms.2022.116964] [Reference Citation Analysis]
6 Nieddu M, Baralla E, Sodano F, Boatto G. Analysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review. Forensic Toxicol 2023;41:1-24. [PMID: 36652064 DOI: 10.1007/s11419-022-00638-6] [Reference Citation Analysis]
7 Salottolo K, Mcguire E, Madayag R, Tanner AH, Carrick MM, Bar-or D. Validity between self-report and biochemical testing of cannabis and drugs among patients with traumatic injury: brief report. J Cannabis Res 2022;4:29. [DOI: 10.1186/s42238-022-00139-8] [Reference Citation Analysis]
8 Neoh MJY, Carollo A, Lim M, Corazza O, Coppola A, Esposito G. The Novel Psychoactive Substances Epidemic: a Scientometric Perspective. Addiction Neuroscience 2022. [DOI: 10.1016/j.addicn.2022.100060] [Reference Citation Analysis]
9 Crulli B, Dines AM, Blanco G, Giraudon I, Eyer F, Liechti ME, Miró Ò, Hovda KE, Heyerdahl F, Yates C, Vallersnes OM, Wood DM, Dargan PI; Euro-DEN Plus Research Group. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019. Clin Toxicol (Phila) 2022;60:1318-27. [PMID: 36322684 DOI: 10.1080/15563650.2022.2137524] [Reference Citation Analysis]
10 Marik B, Mahajan N, Sarkar R, Mitra R, Dua R, Aggarwal S. A Qualitative Assessment among Personnel Working in Community-Led Development Program Settings Regarding Sexualized Substance Use. Brain Sciences 2022;12:1590. [DOI: 10.3390/brainsci12111590] [Reference Citation Analysis]
11 Chaves TV, Wilffert B, Sanchez ZM. Overdoses and deaths related to the use of ketamine and its analogues: a systematic review. The American Journal of Drug and Alcohol Abuse 2022. [DOI: 10.1080/00952990.2022.2132506] [Reference Citation Analysis]
12 Luethi D, Maier J, Rudin D, Szöllősi D, Angenoorth TJF, Stankovic S, Schittmayer M, Burger I, Yang J, Jaentsch K, Holy M, Das AK, Brameshuber M, Camacho-hernandez GA, Casiraghi A, Newman AH, Kudlacek O, Birner-gruenberger R, Stockner T, Schütz GJ, Sitte HH. Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux. Commun Biol 2022;5:1259. [DOI: 10.1038/s42003-022-04210-1] [Reference Citation Analysis]
13 Mayer FP, Niello M, Cintulova D, Sideromenos S, Maier J, Li Y, Bulling S, Kudlacek O, Schicker K, Iwamoto H, Deng F, Wan J, Holy M, Katamish R, Sandtner W, Li Y, Pollak DD, Blakely RD, Mihovilovic MD, Baumann MH, Sitte HH. Serotonin-releasing agents with reduced off-target effects. Mol Psychiatry 2022. [DOI: 10.1038/s41380-022-01843-w] [Reference Citation Analysis]
14 Kim OH, Jeon KO, Jang EY. Alpha-pyrrolidinopentiothiophenone (α-PVT) activates the TLR-NF-κB-MAPK signaling pathway and proinflammatory cytokine production and induces behavioral sensitization in mice. Pharmacol Biochem Behav 2022;221:173484. [PMID: 36272636 DOI: 10.1016/j.pbb.2022.173484] [Reference Citation Analysis]
15 Krishnan RY, Manikandan S, Subbaiya R, Biruntha M, Balachandar R, Karmegam N. Origin, transport and ecological risk assessment of illicit drugs in the environment – A review. Chemosphere 2022. [DOI: 10.1016/j.chemosphere.2022.137091] [Reference Citation Analysis]
16 Oliveira NG, Dinis-oliveira RJ. Genotoxic Aspects of Psychoactive Substances. Psychoactives 2022;1:64-69. [DOI: 10.3390/psychoactives1020007] [Reference Citation Analysis]
17 López-arnau R, Camarasa J, Carbó M, Nadal-gratacós N, Puigseslloses P, Espinosa-velasco M, Urquizu E, Escubedo E, Pubill D. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Front Psychiatry 2022;13:990405. [DOI: 10.3389/fpsyt.2022.990405] [Reference Citation Analysis]
18 Simão AY, Oliveira P, Rosendo LM, Rosado T, Andraus M, Barroso M, Gallardo E. Microextraction by packed sorbent as clean-up approach for the determination of ketamine and norketamine in hair by gas chromatography-tandem mass spectrometry. J Anal Toxicol 2022:bkac075. [PMID: 36124733 DOI: 10.1093/jat/bkac075] [Reference Citation Analysis]
19 Gall AJ, Shuboni-mulligan DD. Keep Your Mask On: The Benefits of Masking for Behavior and the Contributions of Aging and Disease on Dysfunctional Masking Pathways. Front Neurosci 2022;16:911153. [DOI: 10.3389/fnins.2022.911153] [Reference Citation Analysis]
20 Lelievre B, Dupont V, Buchaillet C, Jousset N, Deguigne M, Cirimele V. Difficulties interpreting concentrations in fatal cases: example of 2,5-dimethoxy-4-chloroamphetamine. Forensic Toxicol 2022;40:383-92. [PMID: 36454420 DOI: 10.1007/s11419-022-00628-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mazdai L, Fabbri M, Tirri M, Corli G, Arfè R, Marchetti B, Bilel S, Bergamin E, Gaudio RM, Rubini M, De-giorgio F, Marti M. Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones. Biomedicines 2022;10:1398. [DOI: 10.3390/biomedicines10061398] [Reference Citation Analysis]
22 Demin KA, Kupriyanova OV, Shevyrin VA, Derzhavina KA, Krotova NA, Ilyin NP, Kolesnikova TO, Galstyan DS, Kositsyn YM, Khaybaev AS, Seredinskaya MV, Dubrovskii Y, Sadykova RG, Nerush MO, Mor MS, Petersen EV, Strekalova T, Efimova EV, Kuvarzin SR, Yenkoyan KB, Bozhko DV, Myrov VO, Kolchanova SM, Polovian AI, Galumov GK, Kalueff AV. Acute behavioral and Neurochemical Effects of Novel N-Benzyl-2-Phenylethylamine Derivatives in Adult Zebrafish. ACS Chem Neurosci 2022. [PMID: 35671176 DOI: 10.1021/acschemneuro.2c00123] [Reference Citation Analysis]
23 He K. Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs. J Cheminform 2022;14. [DOI: 10.1186/s13321-022-00607-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kolaczynska KE, Ducret P, Trachsel D, Hoener MC, Liechti ME, Luethi D. Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: ,α-DEPEA and DPIA. European Neuropsychopharmacology 2022;59:9-22. [DOI: 10.1016/j.euroneuro.2022.03.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lenzi M, Gasperini S, Cocchi V, Tirri M, Marti M, Hrelia P. Genotoxicological Characterization of (±)cis-4,4'-DMAR and (±)trans-4,4'-DMAR and Their Association. Int J Mol Sci 2022;23:5849. [PMID: 35628658 DOI: 10.3390/ijms23105849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Tirri M, Bilel S, Arfè R, Corli G, Marchetti B, Bernardi T, Boccuto F, Serpelloni G, Botrè F, De-Giorgio F, Golembiowska K, Marti M. Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs. Front Psychiatry 2022;13:875722. [PMID: 35530025 DOI: 10.3389/fpsyt.2022.875722] [Reference Citation Analysis]
27 Dinis-oliveira RJ. The Genesis of a New Open-Access Journal Focused on the Latest Scientific Advances in Psychoactive Substances. Psychoactives 2022;1:1-6. [DOI: 10.3390/psychoactives1010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ford H, Fraser CL, Solly E, Clough M, Fielding J, White O, Van Der Walt A. Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature. Front Neurol 2022;13:878609. [DOI: 10.3389/fneur.2022.878609] [Reference Citation Analysis]
29 Islas ÁA, Scior T. Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations. Molecules 2022;27:2977. [PMID: 35566327 DOI: 10.3390/molecules27092977] [Reference Citation Analysis]
30 Preuss UW, Schoett K. Cathinone und synthetische Cannabinoide. Suchttherapie 2022;23:94-106. [DOI: 10.1055/a-1742-6016] [Reference Citation Analysis]
31 Mallaroni P, Mason NL, Vinckenbosch FRJ, Ramaekers JG. The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides. Psychopharmacology (Berl) 2022. [PMID: 35487983 DOI: 10.1007/s00213-022-06142-4] [Reference Citation Analysis]
32 Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol 2022:bkac023. [PMID: 35445267 DOI: 10.1093/jat/bkac023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Weng TI, Chen HY, Chin LW, Chou HH, Wu MH, Chen GY, Chen JY, Shih CP, Lin CC, Fang CC. Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department. Clin Toxicol (Phila) 2022;:1-7. [PMID: 35438590 DOI: 10.1080/15563650.2022.2062376] [Reference Citation Analysis]
34 Simão AY, Antunes M, Cabral E, Oliveira P, Rosendo LM, Brinca AT, Alves E, Marques H, Rosado T, Passarinha LA, Andraus M, Barroso M, Gallardo E. An Update on the Implications of New Psychoactive Substances in Public Health. Int J Environ Res Public Health 2022;19:4869. [PMID: 35457736 DOI: 10.3390/ijerph19084869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
35 Zhu A, Zheng F, Zhang W, Li L, Li Y, Hu H, Wu Y, Bao W, Li G, Wang Q, Li H. Oxidation and Antioxidation of Natural Products in the Model Organism Caenorhabditiselegans. Antioxidants 2022;11:705. [DOI: 10.3390/antiox11040705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Espinosa-velasco M, Reguilón MD, Bellot M, Nadal-gratacós N, Berzosa X, Gómez-canela C, Rodríguez-arias M, Camarasa J, Escubedo E, Pubill D, López-arnau R. Repeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Curtis B, Mahat B, Macklin M, Mihalo J, Dakroub AH. Acute Kidney Injury Related to Intoxication From Synthetic Cannabis: Don’t You Know That You’re Toxic? Cureus 2022. [DOI: 10.7759/cureus.23427] [Reference Citation Analysis]
38 Welz A, Koba M, Kośliński P, Siódmiak J. Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs. J Clin Med 2022;11:1758. [PMID: 35407366 DOI: 10.3390/jcm11071758] [Reference Citation Analysis]
39 Netzer K, Balmith M, Flepisi B. Factors affecting the control of new psychoactive substances. South African General Practitioner 2022;3:15-18. [DOI: 10.36303/sagp.2022.3.1.0106] [Reference Citation Analysis]
40 Charunyanont Y, Tubtimrattana A, Tansrisawad N, Thirati P. Effect of Body Refrigeration on the Postmortem Formation of Gamma Hydroxybutyrate in Whole Blood. Forensic Science International 2022. [DOI: 10.1016/j.forsciint.2022.111247] [Reference Citation Analysis]
41 Kolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME. Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines. Front Pharmacol 2021;12:794254. [PMID: 35222010 DOI: 10.3389/fphar.2021.794254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Herian M, Wojtas A, Maćkowiak M, Wawrzczak-Bargiela A, Solarz A, Bysiek A, Madej K, Gołembiowska K. Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe. Sci Rep 2022;12:2939. [PMID: 35190675 DOI: 10.1038/s41598-022-07069-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Nadal-gratacós N, Lleixà E, Gibert-serramià M, Estrada-tejedor R, Berzosa X, Batllori X, Pubill D, Camarasa J, Escubedo E, López-arnau R. Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted α-PVP (“flakka”) Derivatives. IJMS 2022;23:2226. [DOI: 10.3390/ijms23042226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Poyatos L, Torres A, Papaseit E, Pérez-Mañá C, Hladun O, Núñez-Montero M, de la Rosa G, Torrens M, Fuster D, Muga R, Farré M. Abuse Potential of Cathinones in Humans: A Systematic Review. J Clin Med 2022;11:1004. [PMID: 35207278 DOI: 10.3390/jcm11041004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Shin D, Kwon J, Kang H, Suh J, Lee E. The presence of unauthorized ingredients in dietary supplements: an analysis of the risk warning data in Korea. Journal of Food Composition and Analysis 2022. [DOI: 10.1016/j.jfca.2022.104462] [Reference Citation Analysis]
46 Pottie E, Stove CP. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2A R. J Neurochem 2022. [PMID: 34978711 DOI: 10.1111/jnc.15570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Manchester KR, Waters L, Haider S, Maskell PD. The blood-to-plasma ratio and predicted GABA(A)-binding affinity of designer benzodiazepines. Forensic Toxicol 2022;40:349-56. [PMID: 36454409 DOI: 10.1007/s11419-022-00616-y] [Reference Citation Analysis]
48 Büttner A. Grundlegende Substanzmerkmale und neuropathologische Befunde bei Drogenkonsumenten. Neuropathologie des Drogenmissbrauchs 2022. [DOI: 10.1007/978-3-031-13619-1_4] [Reference Citation Analysis]
49 Corli G, Tirri M, Arfè R, Bilel S, Marchetti B, Gregori A, Di Rosa F, Vincenzi F, De-giorgio F, Borea PA, Varani K, Marti M. Behavioral and binding studies on the quinolinyl ester indoles 5F-PB22 (5F-QUPIC) and BB-22 (QUCHIC) in the mouse model. Emerging Trends in Drugs, Addictions, and Health 2022;2:100039. [DOI: 10.1016/j.etdah.2022.100039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kurach Ł, Chłopaś-Konowałek A, Budzyńska B, Zawadzki M, Szpot P, Boguszewska-Czubara A. Etazene induces developmental toxicity in vivo Danio rerio and in silico studies of new synthetic opioid derivative. Sci Rep 2021;11:24269. [PMID: 34931035 DOI: 10.1038/s41598-021-03804-9] [Reference Citation Analysis]
51 Sinenchenko AG, Batotsyrenov CB, Lodyagin AN, Sinenchenko GI, Kovalenko AL. Delirium in Acute Poisoning with 1,4-Butanediol and Its Correction. Obŝaâ reanimatologiâ 2021;17:42-48. [DOI: 10.15360/1813-9779-2021-6-42-48] [Reference Citation Analysis]
52 Welz A, Koba M, Kośliński P, Siódmiak J. Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs. J Clin Med 2021;10:5813. [PMID: 34945109 DOI: 10.3390/jcm10245813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Niebel A, Pragst F, Krumbiegel F, Hartwig S. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs. Forensic Sci Int 2021;331:111148. [PMID: 34923263 DOI: 10.1016/j.forsciint.2021.111148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Gilbert N, Costello A, Ellison JR, Khan U, Knight M, Linnell MJ, Ralphs R, Mewis RE, Sutcliffe OB. Synthesis, characterisation, detection and quantification of a novel hexyl-substituted synthetic cannabinoid receptor agonist: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA). Forensic Chemistry 2021;26:100354. [DOI: 10.1016/j.forc.2021.100354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 He K. Filter Feature Selection for Unsupervised Clustering of Designer Drugs Using DFT Simulated IR Spectra Data. ACS Omega 2021;6:32151-65. [PMID: 34870036 DOI: 10.1021/acsomega.1c04945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Glatfelter GC, Partilla JS, Baumann MH. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice. Neuropsychopharmacology 2021. [PMID: 34802041 DOI: 10.1038/s41386-021-01227-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
57 Rudin D, McCorvy JD, Glatfelter GC, Luethi D, Szöllősi D, Ljubišić T, Kavanagh PV, Dowling G, Holy M, Jaentsch K, Walther D, Brandt SD, Stockner T, Baumann MH, Halberstadt AL, Sitte HH. (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology 2021. [PMID: 34750565 DOI: 10.1038/s41386-021-01221-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yu J, Wu Q, Wu Y, Li J, Wu Q, Cao H, Wang Z. Prevalence of and Factors Associated with Club Drug Use among Secondary Vocational Students in China. Int J Environ Res Public Health 2021;18:10408. [PMID: 34639708 DOI: 10.3390/ijerph181910408] [Reference Citation Analysis]
59 Walia N, Lat JO, Tariq R, Tyagi S, Qazi AM, Salari SW, Jafar A, Kousar T, Renzu M, Leszkowitz D, Abreu R, Rodriguez I. Trends in Mortality Due to Stimulants Use in Adolescents and Young Adults. Addictive Disorders & Their Treatment 2021;20:571-577. [DOI: 10.1097/adt.0000000000000294] [Reference Citation Analysis]
60 Kolaczynska KE, Thomann J, Hoener MC, Liechti ME. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative. Int J Mol Sci 2021;22:8277. [PMID: 34361040 DOI: 10.3390/ijms22158277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
61 Bilel S, Tirri M, Arfè R, Sturaro C, Fantinati A, Cristofori V, Bernardi T, Boccuto F, Cavallo M, Cavalli A, De-Giorgio F, Calò G, Marti M. In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCP. Int J Mol Sci 2021;22:7659. [PMID: 34299276 DOI: 10.3390/ijms22147659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Preuss UW, Schoett K. Cathinone und synthetische Cannabinoide. PSYCH up2date 2021;15:291-303. [DOI: 10.1055/a-1237-7752] [Reference Citation Analysis]
63 Sogos V, Caria P, Porcedda C, Mostallino R, Piras F, Miliano C, De Luca MA, Castelli MP. Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances. Int J Mol Sci 2021;22:6785. [PMID: 34202634 DOI: 10.3390/ijms22136785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Rudin D, Liechti ME, Luethi D. Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Exp Neurol 2021;343:113778. [PMID: 34090893 DOI: 10.1016/j.expneurol.2021.113778] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
65 Institóris L, Kovács K, Sija É, Berkecz R, Körmöczi T, Németh I, Elek I, Bakos Á, Urbán I, Pap C, Kereszty É. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19). Clin Toxicol (Phila) 2021;:1-7. [PMID: 34080493 DOI: 10.1080/15563650.2021.1928162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
66 Bolt HM, Hengstler JG. Commemorating 85 years of publications on Cannabis by Archives of Toxicology. Arch Toxicol 2021;95:2231-3. [PMID: 34052890 DOI: 10.1007/s00204-021-03079-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Giorgetti A, Pascali JP, Fais P, Pelletti G, Gabbin A, Franchetti G, Cecchetto G, Viel G. Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications. Life (Basel) 2021;11:440. [PMID: 34068903 DOI: 10.3390/life11050440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 Puneeth GR, Mahesh SR, Adithya H, Bhargava SJ, Kumari HAC, Gururaj HL, Hong L. Analysis of Drug Classification using Mechanism of Action. J Phys : Conf Ser 2021;1914:012034. [DOI: 10.1088/1742-6596/1914/1/012034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Murata T, Noritake K, Aki T, Uemura K. Possible roles of AMPK and macropinocytosis in the defense responses against Δ9-THC toxicity on HL-1 cardiomyocytes. Toxicol Rep 2021;8:980-7. [PMID: 34026562 DOI: 10.1016/j.toxrep.2021.04.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, Vento A, Schifano F. Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise. Eur Neuropsychopharmacol 2021;49:69-92. [PMID: 33857740 DOI: 10.1016/j.euroneuro.2021.03.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
71 Niello M, Cintulová D, Raithmayr P, Holy M, Jäntsch K, Colas C, Ecker GF, Sitte HH, Mihovilovic MD. Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro. Front Pharmacol 2021;12:654061. [PMID: 33897439 DOI: 10.3389/fphar.2021.654061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
72 Lapostolle F, Beaune S. Ecstasy : la deuxième vague…. Ann Fr Med Urgence 2021;11:100-11. [DOI: 10.3166/afmu-2021-0309] [Reference Citation Analysis]
73 Savulich G, Bowden-Jones O, Stephenson R, Brühl AB, Ersche KD, Robbins TW, Sahakian BJ. "Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances. Front Psychiatry 2021;12:660575. [PMID: 33841219 DOI: 10.3389/fpsyt.2021.660575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
74 Brandon AM, Antonides LH, Riley J, Epemolu O, McKeown DA, Read KD, McKenzie C. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market. Molecules 2021;26:1396. [PMID: 33807614 DOI: 10.3390/molecules26051396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
75 Pottie E, Kupriyanova OV, Brandt AL, Laprairie RB, Shevyrin VA, Stove CP. Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking. ACS Pharmacol Transl Sci 2021;4:479-87. [PMID: 33860178 DOI: 10.1021/acsptsci.0c00189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
76 Hagino Y, Hall FS, Uhl GR, Sora I, Ikeda K. Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT1A receptor in the mouse striatum and prefrontal cortex. Neuropsychopharmacol Rep 2021;41:91-101. [PMID: 33547882 DOI: 10.1002/npr2.12161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
77 Jensen O, Rafehi M, Gebauer L, Brockmöller J. Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers? Front Pharmacol 2020;11:609811. [PMID: 33551812 DOI: 10.3389/fphar.2020.609811] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
78 Tai H, Swartz MD, Marsden D, Perry CL. The Future of Substance Abuse Now: Relationships among Adolescent Use of Vaping Devices, Marijuana, and Synthetic Cannabinoids. Substance Use & Misuse 2021;56:192-204. [DOI: 10.1080/10826084.2020.1849305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
79 Floresta G, Abbate V. Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification. RSC Adv 2021;11:14587-14595. [DOI: 10.1039/d1ra01335a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Büttner A. Basic Substance Characteristics and Neuropathological Findings in Drug Abusers. Neuropathology of Drug Abuse 2021. [DOI: 10.1007/978-3-030-60531-5_4] [Reference Citation Analysis]
81 Carlier J, Diao X, Giorgetti R, Busardò FP, Huestis MA. Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations. Int J Mol Sci 2020;22:E230. [PMID: 33379373 DOI: 10.3390/ijms22010230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Cocchi V, Gasperini S, Hrelia P, Tirri M, Marti M, Lenzi M. Novel Psychoactive Phenethylamines: Impact on Genetic Material. Int J Mol Sci 2020;21:E9616. [PMID: 33348640 DOI: 10.3390/ijms21249616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
83 Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. New psychoactive substances: a review and updates. Ther Adv Psychopharmacol 2020;10:2045125320967197. [PMID: 33414905 DOI: 10.1177/2045125320967197] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
84 Antonides LH, Cannaert A, Norman C, NicDáeid N, Sutcliffe OB, Stove CP, McKenzie C. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons. Drug Test Anal 2021;13:628-43. [PMID: 33161649 DOI: 10.1002/dta.2965] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
85 Tran T, Ball J, Bratberg JP, DeSimone EM, Franko TS, Hill LG, Sharp CPK, Palombi L, Ventricelli D, Farrell D, Gandhi N, Moore T. Report of the 2020 Special Committee on Substance Use and Pharmacy Education. Am J Pharm Educ 2020;84:8421. [PMID: 34283760 DOI: 10.5688/ajpe8421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
86 Patocka J, Zhao B, Wu W, Klimova B, Valis M, Nepovimova E, Kuca K. Flakka: New Dangerous Synthetic Cathinone on the Drug Scene. Int J Mol Sci 2020;21:E8185. [PMID: 33142953 DOI: 10.3390/ijms21218185] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
87 Brandt SD, Walters HM, Partilla JS, Blough BE, Kavanagh PV, Baumann MH. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats. Psychopharmacology (Berl) 2020;237:3703-14. [PMID: 32875347 DOI: 10.1007/s00213-020-05648-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
88 Tirri M, Ponzoni L, Bilel S, Arfè R, Braida D, Sala M, Marti M. Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish. Brain Sci 2020;10:E586. [PMID: 32847111 DOI: 10.3390/brainsci10090586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Pottie E, Cannaert A, Stove CP. In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor. Arch Toxicol 2020;94:3449-60. [PMID: 32627074 DOI: 10.1007/s00204-020-02836-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
90 Hamnett HJ, Dror IE. The effect of contextual information on decision-making in forensic toxicology. Forensic Sci Int Synerg 2020;2:339-48. [PMID: 33385132 DOI: 10.1016/j.fsisyn.2020.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
91 Kumar A, Kumar P. Construction of pioneering quantitative structure activity relationship screening models for abuse potential of designer drugs using index of ideality of correlation in monte carlo optimization. Arch Toxicol 2020;94:3069-86. [DOI: 10.1007/s00204-020-02828-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
92 Malik K, Kommana S, Paul J, Krakauer M. Synthetic cannabinoid induced ocular self-injury. Orbit 2021;40:326-8. [PMID: 32552411 DOI: 10.1080/01676830.2020.1781199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]